Catalyst
Slingshot members are tracking this event:
Eisai has entered the generic pharmaceutical business in China through the acquisition of Liaoning TianYi Biological
- Source Link:
- http://www.eisai.com/news/news201588.html
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EII.F |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 28, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acquisition, China, Business License, Generic, Market
